LBH-589 [404950-80-7]
L0528
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameLBH-589 [404950-80-7]
- Delivery Days Customer7
- Estimated Purity≥98%
- FormatDMSO 69 mg/mL (197.46 mM); Water Insoluble; Ethanol Insoluble
- Scientific DescriptionHDAC1/2/3/11 inhibitor.; LBH589, Panobinostat
- Storage Instruction-20°C
- UNSPSC12352200
References
- Andreu-Vieyra CV, Berenson JR. The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma. Ther Adv Hematol. 2014 Dec;5(6):197-210. PMID: 25469210. Rhodes LV, Tate CR, Segar HC, et al. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Breast Cancer Res Treat. 2014 Jun;145(3):593-604. PMID: 24810497. Henrici A, Montalbano R, Neureiter D, et al. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines. Mol Carcinog. 2013 Dec 23. [Epub ahead of print]. PMID: 24375802.